Aiming to become the global leader in chip-scale photonic solutions by deploying Optical Interposer technology to enable the seamless integration of electronics and photonics for a broad range of vertical market applications

Free
Message: Off topic but interesting

This was a hoax news release. Unbelievable.

ImmunoVaccine did not issue PR Web news release

2015-02-27 09:42 PT - News Release

Dr. Marc Mansour reports

IMMUNOVACCINE DISCLAIMS HOAX PRESS RELEASE

ImmunoVaccine Inc. has been made aware of a fraudulent press release disseminated this morning by PR Web, and redistributed by GlobeNewswire, purporting to be from ImmunoVaccine. This press release states that ImmunoVaccine has entered into a co-development agreement with Gilead Science Inc. The press release did not originate from ImmunoVaccine and there is no accuracy to the information contained within the press release. Please note that all official statements by ImmunoVaccine are made via Marketwired. Any statements made through other means should be treated with caution and may well be fraudulent.

We seek Safe Harbor.

Share
New Message
Please login to post a reply